Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
ovid
/
Ovid Therapeutics Inc
OVID
Add to Watchlist
2.220
USD
-0.150
-6.33%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
2.370
USD
+2.370
After-hours 08/03, 20:00 (ET)
414.34M
Market Cap
Loss
P/E TTM
Ovid Therapeutics Inc
2.220
-0.150
-6.33%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
5.74%
Takeda Pharmaceutical Co Ltd
4.71%
Affinity Asset Advisors LLC
3.83%
Vanguard Capital Management, LLC
2.82%
Adar1 Capital Management LLC
2.30%
Other
80.61%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
5.74%
Takeda Pharmaceutical Co Ltd
4.71%
Affinity Asset Advisors LLC
3.83%
Vanguard Capital Management, LLC
2.82%
Adar1 Capital Management LLC
2.30%
Other
80.61%
Shareholder Types
Shareholders
Proportion
Hedge Fund
17.65%
Investment Advisor
7.10%
Venture Capital
6.38%
Corporation
5.08%
Investment Advisor/Hedge Fund
5.05%
Individual Investor
2.46%
Research Firm
1.20%
Pension Fund
0.07%
Other
55.02%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
217
67.84M
39.21%
+12.81M
2025Q4
198
43.75M
33.60%
-2.41M
2025Q3
176
23.96M
33.70%
-28.43M
2025Q2
176
46.12M
64.86%
-16.45M
2025Q1
183
51.39M
72.29%
-10.07M
2024Q4
181
52.28M
73.63%
-8.46M
2024Q3
175
51.32M
72.31%
-10.19M
2024Q2
172
51.56M
72.67%
-6.81M
2024Q1
174
55.84M
78.97%
-6.53M
2023Q4
174
57.32M
81.09%
-4.46M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
10.71M
7.09%
+10.71M
--
Dec 31, 2025
Takeda Pharmaceutical Co Ltd
8.78M
5.81%
+1.25M
+16.60%
Dec 08, 2025
Affinity Asset Advisors LLC
7.15M
4.73%
--
--
Jan 22, 2026
Adar1 Capital Management LLC
4.29M
2.84%
+4.27M
+33256.69%
Dec 31, 2025
Eventide Asset Management, LLC
4.29M
2.84%
+4.29M
--
Dec 31, 2025
Levin (Jeremy M)
3.77M
2.5%
+47.33K
+1.27%
Mar 23, 2026
Federated Hermes Global Investment Management Corp.
3.57M
2.36%
+3.57M
--
Dec 31, 2025
Point72 Asset Management, L.P.
3.55M
2.35%
+3.55M
--
Dec 31, 2025
Adage Capital Management, L.P.
3.49M
2.31%
+2.14M
+158.67%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
0%
ProShares UltraPro Russell2000
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Ultra Nasdaq Biotechnology
0%
Invesco Nasdaq Biotechnology ETF
0%
Fidelity Enhanced Small Cap ETF
0%
ProShares Hedge Replication ETF
0%
Avantis Responsible US Equity ETF
0%
View more
iShares Russell 2000 Growth ETF
Proportion
0%
iShares Micro-Cap ETF
Proportion
0%
ProShares UltraPro Russell2000
Proportion
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion
0%
Proshares Ultra Russell 2000
Proportion
0%
ProShares Ultra Nasdaq Biotechnology
Proportion
0%
Invesco Nasdaq Biotechnology ETF
Proportion
0%
Fidelity Enhanced Small Cap ETF
Proportion
0%
ProShares Hedge Replication ETF
Proportion
0%
Avantis Responsible US Equity ETF
Proportion
0%